Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 268 | 3 | HEPATOCELLULAR CARCINOMA//HEPATECTOMY//LIVER RESECTION | 44698 |
| 526 | 2 | HEPATOCELLULAR CARCINOMA//HEPATOBLASTOMA//ALPHA FETOPROTEIN | 15421 |
| 4743 | 1 | SORAFENIB//HEPATOCELLULAR CARCINOMA//HEPATIC ARTERIAL INFUSION CHEMOTHERAPY | 1760 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | SORAFENIB | authKW | 2380205 | 30% | 25% | 523 |
| 2 | HEPATOCELLULAR CARCINOMA | authKW | 634111 | 49% | 4% | 862 |
| 3 | HEPATIC ARTERIAL INFUSION CHEMOTHERAPY | authKW | 466128 | 3% | 48% | 54 |
| 4 | ADVANCED HEPATOCELLULAR CARCINOMA | authKW | 389060 | 2% | 59% | 37 |
| 5 | ADVANCED HCC | authKW | 144087 | 1% | 62% | 13 |
| 6 | GIDEON | authKW | 97483 | 0% | 78% | 7 |
| 7 | BRIVANIB | authKW | 95483 | 1% | 44% | 12 |
| 8 | SORAFENIB ANALOGS | authKW | 89528 | 0% | 100% | 5 |
| 9 | MT SINAI LIVER CANC PROGRAM | address | 83918 | 1% | 25% | 19 |
| 10 | LIVER CANCER | journal | 62793 | 1% | 18% | 20 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 16226 | 50% | 0% | 877 |
| 2 | Gastroenterology & Hepatology | 15849 | 28% | 0% | 499 |
| 3 | Pharmacology & Pharmacy | 359 | 11% | 0% | 190 |
| 4 | Medicine, Research & Experimental | 43 | 3% | 0% | 55 |
| 5 | Cell Biology | 34 | 4% | 0% | 79 |
| 6 | Surgery | 30 | 5% | 0% | 82 |
| 7 | Chemistry, Medicinal | 25 | 2% | 0% | 34 |
| 8 | Pathology | 22 | 2% | 0% | 30 |
| 9 | Medicine, General & Internal | 13 | 3% | 0% | 55 |
| 10 | Integrative & Complementary Medicine | 1 | 0% | 0% | 4 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | MT SINAI LIVER CANC PROGRAM | 83918 | 1% | 25% | 19 |
| 2 | FDN IRCCS CA GRANDA MAGGIORE HOSP | 58595 | 0% | 55% | 6 |
| 3 | BARCELONA CLIN LIVER CANC GRP | 56999 | 1% | 29% | 11 |
| 4 | BCLC GRP | 50369 | 1% | 26% | 11 |
| 5 | MEDBIOL HUMAINE | 40286 | 0% | 75% | 3 |
| 6 | ANGIOGENESIS CANC AMSTERDAM | 35811 | 0% | 100% | 2 |
| 7 | ANGIOGENESIS INHIBITORS MED ONCOL | 35811 | 0% | 100% | 2 |
| 8 | ANGIOGENESIS INHIBITORS MULTIDISCIPLINARY STUDY G | 35811 | 0% | 100% | 2 |
| 9 | BARCELONA CLIN LIVER CANC BCLC GRPRADIOL | 35811 | 0% | 100% | 2 |
| 10 | BARCELONA CLIN LIVER CANC GRP BCLC | 35811 | 0% | 100% | 2 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | LIVER CANCER | 62793 | 1% | 18% | 20 |
| 2 | HEPATOLOGY RESEARCH | 12347 | 3% | 2% | 44 |
| 3 | ONCOLOGY | 8621 | 3% | 1% | 44 |
| 4 | JOURNAL OF HEPATOLOGY | 5740 | 3% | 1% | 50 |
| 5 | LIVER INTERNATIONAL | 4180 | 1% | 1% | 25 |
| 6 | DIGESTIVE DISEASES | 3969 | 1% | 1% | 20 |
| 7 | WORLD JOURNAL OF GASTROENTEROLOGY | 3731 | 3% | 0% | 60 |
| 8 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 3391 | 2% | 1% | 38 |
| 9 | JOURNAL OF GASTROENTEROLOGY | 3297 | 1% | 1% | 26 |
| 10 | ONCOLOGIST | 3045 | 1% | 1% | 20 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SORAFENIB | 2380205 | 30% | 25% | 523 | Search SORAFENIB | Search SORAFENIB |
| 2 | HEPATOCELLULAR CARCINOMA | 634111 | 49% | 4% | 862 | Search HEPATOCELLULAR+CARCINOMA | Search HEPATOCELLULAR+CARCINOMA |
| 3 | HEPATIC ARTERIAL INFUSION CHEMOTHERAPY | 466128 | 3% | 48% | 54 | Search HEPATIC+ARTERIAL+INFUSION+CHEMOTHERAPY | Search HEPATIC+ARTERIAL+INFUSION+CHEMOTHERAPY |
| 4 | ADVANCED HEPATOCELLULAR CARCINOMA | 389060 | 2% | 59% | 37 | Search ADVANCED+HEPATOCELLULAR+CARCINOMA | Search ADVANCED+HEPATOCELLULAR+CARCINOMA |
| 5 | ADVANCED HCC | 144087 | 1% | 62% | 13 | Search ADVANCED+HCC | Search ADVANCED+HCC |
| 6 | GIDEON | 97483 | 0% | 78% | 7 | Search GIDEON | Search GIDEON |
| 7 | BRIVANIB | 95483 | 1% | 44% | 12 | Search BRIVANIB | Search BRIVANIB |
| 8 | SORAFENIB ANALOGS | 89528 | 0% | 100% | 5 | Search SORAFENIB+ANALOGS | Search SORAFENIB+ANALOGS |
| 9 | CHILD PUGH B | 57296 | 0% | 80% | 4 | Search CHILD+PUGH+B | Search CHILD+PUGH+B |
| 10 | SORAFENIB N OXIDE | 57296 | 0% | 80% | 4 | Search SORAFENIB+N+OXIDE | Search SORAFENIB+N+OXIDE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |